Atıf Formatları
Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. U. ABACIOGLU Et Al. , "Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma," JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3, pp.585-593, 2011

ABACIOGLU, M. U. Et Al. 2011. Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma. JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3 , 585-593.

ABACIOGLU, M. U., Caglar, H. B., Yumuk, P. F., Akgun, Z., ATASOY, B. M., & Sengoz, M., (2011). Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma. JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3, 585-593.

ABACIOGLU, MEHMET Et Al. "Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma," JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3, 585-593, 2011

ABACIOGLU, MEHMET U. Et Al. "Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma." JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3, pp.585-593, 2011

ABACIOGLU, M. U. Et Al. (2011) . "Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma." JOURNAL OF NEURO-ONCOLOGY , vol.103, no.3, pp.585-593.

@article{article, author={MEHMET UFUK ABACIOGLU Et Al. }, title={Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma}, journal={JOURNAL OF NEURO-ONCOLOGY}, year=2011, pages={585-593} }